Effects of intravenous multiple busulfan injection on suppression of endogenous spermatogenesis in recipient stallion testes.
Heejun JungMinjung YoonPublished in: Journal of animal science and technology (2021)
Preparation of recipient stallions is critical step to produce donor spermatogonial stem cell (SSC) derived sperm using transplantation technique. This study was conducted to evaluate the effects of intravenous busulfan infusion on germ cell depletion, semen production, and libido in stallions. Six Thoroughbred stallions were separated into two treatment groups: 1) a multiple low-dose (2.5 mg/kg bw for the first 4 weeks and 5 mg/kg bw for the 5th week); and 2) control group treated with PBS. Testicular samples were obtained at 11 weeks and classified into three different patterns of spermatogenesis, such as normal, Sertoli cell only, and destroyed. Semen collection and libido experiments were performed 1 week before treatment, and 4 and 8 weeks after treatment. For the sperm analysis, total spermatozoa and motility were measured using a light microscope with a motility analyzing system. In the multiple low-dose group, the numbers of tubules categorized as Sertoli cell only were significantly higher than those in the control as well as the total population and total/progressive motility of sperm were significantly decreased 8 weeks after the start of the treatment. The sperm production and motility in the multiple low-dose group appears to be reduced, while libido was maintained. In conclusion, multiple administration of 2.5 mg/kg bw busulfan depletes endogenous germ cells in the stallion recipients for SSC transplantation.
Keyphrases
- low dose
- high dose
- stem cells
- cell therapy
- biofilm formation
- germ cell
- single cell
- clinical trial
- multiple sclerosis
- combination therapy
- escherichia coli
- staphylococcus aureus
- oxidative stress
- acute lymphoblastic leukemia
- allogeneic hematopoietic stem cell transplantation
- candida albicans
- acute myeloid leukemia
- kidney transplantation
- cystic fibrosis
- newly diagnosed
- pseudomonas aeruginosa